Exploiting the Body's Immune System to Treat a Broad Range of Diseases

Read more

ARMO in the News

9/9/2017

ARMO BioSciences’s Phase 1b Trials Demonstrate Continued Promising Response Rates and Survival in Patients with Advanced Pancreatic Cancer, NSCLC, and RCC  Read more

8/29/2017

ARMO BioSciences Raises $67 Million in a Series C-1 Financing  Read more